Diet-dependent cardiovascular lipid metabolism controlled by hepatic LXRα
The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Hepatic LXR overexpression has been reported to upregulate cholesterol removal genes such as Abcg5/826, which is consistent with our findings.”
From TTC39B deficiency stabilizes LXR reducing both atherosclerosis and steatohepatitis (2016) · cites this paper as [26]
In the citing paper
“However, there were minimal effects on SREBP-1 target genes26, suggesting that decreased LXR ubiquitination may also contribute to the decreased lipogenesis in T39-/- mice.”
From TTC39B deficiency stabilizes LXR reducing both atherosclerosis and steatohepatitis (2016) · cites this paper as [26]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The coregulator exchange in transcriptional functions of nuclear receptors
Glass, C. K., & Rosenfeld, M. G. (2000) · Genes & Development · doi:10.1101/gad.14.2.121 · Cited by 2,233 · cited 1×
“two states that either repress or activate transcription of these genes (Glass and Rosenfeld, 2000; McKenna and O’Malley, 2002).”
BackgroundNuclear Receptors and Lipid Physiology: Opening the X-Files
Chawla, A., Repa, J. J., Evans, R. M., & Mangelsdorf, D. J. (2001) · Science · doi:10.1126/science.294.5548.1866 · Cited by 2,085
Combinatorial Control of Gene Expression by Nuclear Receptors and Coregulators
McKenna, N. J., & O'Malley, B. W. (2002) · Cell · doi:10.1016/s0092-8674(02)00641-4 · Cited by 1,463
An Apolipoprotein Influencing Triglycerides in Humans and Mice Revealed by Comparative Sequencing
Pennacchio, L. A., Olivier, M., Hubacek, J. A., Cohen, J. C., Cox, D. R., Fruchart, J.-C., Krauss, R. M., & Rubin, E. M. (2001) · Science · doi:10.1126/science.1064852 · Cited by 921 · cited 1×
“ApoA5, a potent mediator of triglyceride reduction via accelerated clearance of triglyceride-rich VLDL (Baroukh et al., 2004; Merkel et al., 2005; Pennacchio et al., 2001), was increased along with ApoA4, which might play a synergistic role in enhancing the uptake of VLDL by increasing LPL activity (Goldberg et al.”
BackgroundAssmann, G., & Schulte, H. (1992) · The American Journal of Cardiology · doi:10.1016/0002-9149(92)90550-i · Cited by 872
PPAR- and LXR-dependent pathways controlling lipid metabolism and the development of atherosclerosis
Li, A. C., & Glass, C. K. (2004) · Journal of Lipid Research · doi:10.1194/jlr.r400010-jlr200 · Cited by 357 · cited 2×
“Liver X receptors (LXRs) have emerged as key regulators of cholesterol and lipid metabolism (Barish and Evans, 2004; Li and Glass, 2004; Tontonoz and Mangelsdorf, 2003).”
Background
Research works printed but not linked: 46
- Barish, 2004, PPARs and LXRs: atherosclerosis goes nuclear, Trends Endocrinol. Metab., 15, 158, 10.1016/j.tem.2004.03.003 · DOI
- Baroukh, 2004, Analysis of apolipoprotein A5, c3, and plasma triglyceride concentrations in genetically engineered mice, Arterioscler. Thromb. Vasc. Biol., 24, 1297, 10.1161/01.ATV.0000130463.68272.1d · DOI · Paper page
- Chiang, 2001, Regulation of cholesterol 7alpha-hydroxylase gene (CYP7A1) transcription by the liver orphan receptor (LXRalpha), Gene, 262, 257, 10.1016/S0378-1119(00)00518-7 · DOI · Paper page
- Chisholm, 2003, The LXR ligand T0901317 induces severe lipogenesis in the db/db diabetic mouse, J. Lipid Res., 44, 2039, 10.1194/jlr.M300135-JLR200 · DOI · Paper page
- DeBose-Boyd, 2001, Expression of sterol regulatory element-binding protein 1c (SREBP-1c) mRNA in rat hepatoma cells requires endogenous LXR ligands, Proc. Natl. Acad. Sci. USA, 98, 1477, 10.1073/pnas.98.4.1477 · DOI · Paper page
- Deeb, 1996, Two novel apolipoprotein A-IV variants in individuals with familial combined hyperlipidemia and diminished levels of lipoprotein lipase activity, Hum. Mutat., 8, 319, 10.1002/(SICI)1098-1004(1996)8:4<319::AID-HUMU4>3.0.CO;2-2 · DOI
- Durrington, 2003, Dyslipidaemia, Lancet, 362, 717, 10.1016/S0140-6736(03)14234-1 · DOI · Paper page
- Foster, 2004, The role of the carnitine system in human metabolism, Ann. N Y Acad. Sci., 1033, 1, 10.1196/annals.1320.001 · DOI · Paper page
- Gao, 2002, Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy, Proc. Natl. Acad. Sci. USA, 99, 11854, 10.1073/pnas.182412299 · DOI · Paper page
- Goldberg, 1990, Lipoprotein ApoC-II activation of lipoprotein lipase. Modulation by apolipoprotein A-IV, J. Biol. Chem., 265, 4266, 10.1016/S0021-9258(19)39557-2 · DOI · Paper page
- Grefhorst, 2002, Stimulation of lipogenesis by pharmacological activation of the liver X receptor leads to production of large, triglyceride-rich very low density lipoprotein particles, J. Biol. Chem., 277, 34182, 10.1074/jbc.M204887200 · DOI · Paper page
- Guan, 2005, Corepressors selectively control the transcriptional activity of PPARgamma in adipocytes, Genes Dev., 19, 453, 10.1101/gad.1263305 · DOI · Paper page
- Gupta, 2002, LXR alpha is the dominant regulator of CYP7A1 transcription, Biochem. Biophys. Res. Commun., 293, 338, 10.1016/S0006-291X(02)00229-2 · DOI
- Horton, 1999, Disruption of LDL receptor gene in transgenic SREBP-1a mice unmasks hyperlipidemia resulting from production of lipid-rich VLDL, J. Clin. Invest., 103, 1067, 10.1172/JCI6246 · DOI · Paper page
- Horton, 2003, Combined analysis of oligonucleotide microarray data from transgenic and knockout mice identifies direct SREBP target genes, Proc. Natl. Acad. Sci. USA, 100, 12027, 10.1073/pnas.1534923100 · DOI · Paper page
- Hu, 2000, Transcriptional repression by nuclear hormone receptors, Trends Endocrinol. Metab., 11, 6, 10.1016/S1043-2760(99)00215-5 · DOI · Paper page
- Hu, 2003, Liver x receptors interact with corepressors to regulate gene expression, Mol. Endocrinol., 17, 1019, 10.1210/me.2002-0399 · DOI · Paper page
- Ishibashi, 1993, Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery, J. Clin. Invest., 92, 883, 10.1172/JCI116663 · DOI · Paper page
- Jakel, 2004, The liver X receptor ligand T0901317 down-regulates APOA5 gene expression through activation of SREBP-1c, J. Biol. Chem., 279, 45462, 10.1074/jbc.M404744200 · DOI · Paper page
- Janowski, 1996, An oxysterol signalling pathway mediated by the nuclear receptor LXR alpha, Nature, 383, 728, 10.1038/383728a0 · DOI · Paper page
- Joseph, 2002, Synthetic LXR ligand inhibits the development of atherosclerosis in mice, Proc. Natl. Acad. Sci. USA, 99, 7604, 10.1073/pnas.112059299 · DOI · Paper page
- Lebherz, 2004, Gene therapy with novel adeno-associated virus vectors substantially diminishes atherosclerosis in a murine model of familial hypercholesterolemia, J. Gene Med., 6, 663, 10.1002/jgm.554 · DOI · Paper page
- Levin, 2005, Macrophage liver X receptor is required for antiatherogenic activity of LXR agonists, Arterioscler. Thromb. Vasc. Biol., 25, 135, 10.1161/01.ATV.0000150044.84012.68 · DOI · Paper page
- Levine, 1995, Cholesterol reduction in cardiovascular disease. Clinical benefits and possible mechanisms, N. Engl. J. Med., 332, 512, 10.1056/NEJM199502233320807 · DOI · Paper page
- Liang, 2004, Liver X receptors (LXRs) regulate apolipoprotein AIV-implications of the antiatherosclerotic effect of LXR agonists, Mol. Endocrinol., 18, 2000, 10.1210/me.2003-0477 · DOI
- Lin, 2005, Hyperlipidemic effects of dietary saturated fats mediated through PGC-1beta coactivation of SREBP, Cell, 120, 261, 10.1016/j.cell.2004.11.043 · DOI · Paper page
- Mak, 2002, Regulated expression of the apolipoprotein E/C-I/C-IV/C-II gene cluster in murine and human macrophages. A critical role for nuclear liver X receptors alpha and beta, J. Biol. Chem., 277, 31900, 10.1074/jbc.M202993200 · DOI · Paper page
- Medh, 2000, Lipoprotein lipase- and hepatic triglyceride lipase-promoted very low density lipoprotein degradation proceeds via an apolipoprotein E-dependent mechanism, J. Lipid Res., 41, 1858, 10.1016/S0022-2275(20)31980-5 · DOI · Paper page
- Merkel, M., Loeffler, B., Kluger, M., Fabig, N., Geppert, G., Pennacchio, L.A., Laatsch, A., and Heeren, J. (2005). Apolipoprotein AV accelerates plasma hydrolysis of triglyceride-rich lipoproteins by interaction with proteoglycan bound lipoprotein lipase. J. Biol. Chem. Published online March 17, 2005. 10.1074/jbc.M411412200. · DOI · Paper page
- Millatt, 2003, Liver X receptors and the control of cholesterol homeostasis: potential therapeutic targets for the treatment of atherosclerosis, Biochim. Biophys. Acta, 1631, 107, 10.1016/S1388-1981(02)00366-9 · DOI
- Ordovas, 2004, Nutritional genomics, Annu. Rev. Genomics Hum. Genet., 5, 71, 10.1146/annurev.genom.5.061903.180008 · DOI · Paper page
- Pastinen, 2004, A survey of genetic and epigenetic variation affecting human gene expression, Physiol. Genomics, 16, 184, 10.1152/physiolgenomics.00163.2003 · DOI · Paper page
- Peet, 1998, The LXRs: a new class of oxysterol receptors, Curr. Opin. Genet. Dev., 8, 571, 10.1016/S0959-437X(98)80013-0 · DOI · Paper page
- Peet, 1998, Cholesterol and bile acid metabolism are impaired in mice lacking the nuclear oxysterol receptor LXR alpha, Cell, 93, 693, 10.1016/S0092-8674(00)81432-4 · DOI · Paper page
- Rader, 2003, Monogenic hypercholesterolemia: new insights in pathogenesis and treatment, J. Clin. Invest., 111, 1795, 10.1172/JCI200318925 · DOI · Paper page
- Repa, 2000, Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRalpha and LXRbeta, Genes Dev., 14, 2819, 10.1101/gad.844900 · DOI · Paper page
- Repa, 2002, Regulation of ATP-binding cassette sterol transporters ABCG5 and ABCG8 by the liver X receptors alpha and beta, J. Biol. Chem., 277, 18793, 10.1074/jbc.M109927200 · DOI · Paper page
- Schultz, 2000, Role of LXRs in control of lipogenesis, Genes Dev., 14, 2831, 10.1101/gad.850400 · DOI · Paper page
- Schuster, 2002, Accumulation of foam cells in liver X receptor-deficient mice, Circulation, 106, 1147, 10.1161/01.CIR.0000026802.79202.96 · DOI · Paper page
- Spady, 1998, Overexpression of cholesterol 7alpha-hydroxylase (CYP7A) in mice lacking the low density lipoprotein (LDL) receptor gene. LDL transport and plasma LDL concentrations are reduced, J. Biol. Chem., 273, 126, 10.1074/jbc.273.1.126 · DOI
- Steffensen, 2004, Genome-wide expression profiling; a panel of mouse tissues discloses novel biological functions of liver X receptors in adrenals, J. Mol. Endocrinol., 33, 609, 10.1677/jme.1.01508 · DOI · Paper page
- Tangirala, 2002, Identification of macrophage liver X receptors as inhibitors of atherosclerosis, Proc. Natl. Acad. Sci. USA, 99, 11896, 10.1073/pnas.182199799 · DOI · Paper page
- Terasaka, 2003, T-0901317, a synthetic liver X receptor ligand, inhibits development of atherosclerosis in LDL receptor-deficient mice, FEBS Lett., 536, 6, 10.1016/S0014-5793(02)03578-0 · DOI · Paper page
- Tontonoz, 2003, Liver X receptor signaling pathways in cardiovascular disease, Mol. Endocrinol., 17, 985, 10.1210/me.2003-0061 · DOI · Paper page
- Wagner, 2003, Promoter-specific roles for liver X receptor/corepressor complexes in the regulation of ABCA1 and SREBP1 gene expression, Mol. Cell. Biol., 23, 5780, 10.1128/MCB.23.16.5780-5789.2003 · DOI · Paper page
- Willy, 1995, LXR, a nuclear receptor that defines a distinct retinoid response pathway, Genes Dev., 9, 1033, 10.1101/gad.9.9.1033 · DOI · Paper page
Cited by
Liver X receptors as regulators of macrophage inflammatory and metabolic pathways
A-González, N., & Castrillo, A. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.12.015 · Cited by 139
TTC39B deficiency stabilizes LXR reducing both atherosclerosis and steatohepatitis
Hsieh, J., Koseki, M., Molusky, M. M., Yakushiji, E., Ichi, I., Westerterp, M., Iqbal, J., Chan, R. B., Abramowicz, S., Tascau, L., et al. (2016) · Nature · doi:10.1038/nature18628 · Cited by 106
Self-citationHan, C. Y., Ki, S. H., Kim, Y. W., Noh, K., Lee, D. Y., Kang, B., Ryu, J.-H., Jeon, R., Kim, E. H., Hwang, S. J., et al. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3190 · Cited by 63
“LXR a may have a favorable effect on cholesterol and glucose metabolism (32).”
Metadata
- Authors
- Lehrke, M., Lebherz, C., Millington, S. C., Guan, H.-P., Millar, J., Rader, D. J., Wilson, J. M., & Lazar, M. A.
- Venue
- Cell Metabolism
- Publisher
- Elsevier BV
- Published
- 2005-05
- Volume
- 1
- Issue
- 5
- Pages
- 297-308
- ISSN
- 1550-4131
- Cited by
- 45
- References
- 6
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 2999 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Diet-dependent cardiovascular lipid metabolism controlled by hepatic LXRα. https://app.cochat.ai/papers/10.1016/j.cmet.2005.04.005
- The paper
- Lehrke, M., Lebherz, C., Millington, S. C., Guan, H.-P., Millar, J., Rader, D. J., Wilson, J. M., & Lazar, M. A. (2005). Diet-dependent cardiovascular lipid metabolism controlled by hepatic LXRα. Cell Metabolism. https://doi.org/10.1016/j.cmet.2005.04.005
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.